Tuesday, March 17, 2026

Mysterious DIVIDEND: Trump Won’t Define ‘Rich’ Because His Tax Break Scheme Is ONLY For The Champagne Class

Trump announces $2,000 dividend from tariffs, causing a surge in cryptocurrency and signs of a rally in U.S. capital markets.

U.S.-Korea Trade Talks: What Did PM Kim Discuss with VP Vance?

Prime Minister Kim Min-seok discussed U.S.-Korea tariffs, Coupang's data breach, and North Korea relations with Vice President Vance in Washington.

Fired for Praise? The Controversial Comments That Cost Coach Palfrey His Job

Coach Michael Palfrey was dismissed from the Australian swimming team for praising Kim Woo Min, affecting team reputation.

Dae Hyun Moon

Author's Latest

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

KIMES 2026: How South Korea’s Medical Device Industry is Poised for Global Expansion

KIMES 2026 showcases Korea's medical device sector, highlighting digital growth and global expansion opportunities for domestic companies.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

Curiosis: Revolutionizing Bio Research with Automated Cell Imaging Systems

Curiosis enhances biomedical research with automated cell analysis, aiming for profitability and becoming a leading lab automation provider.

Revolutionary AI Machine Vision Solutions Unveiled at AW 2026: What You Need to Know

Vieworks showcased advanced imaging solutions at AW 2026, enhancing AI inspection capabilities with next-gen machine vision technologies.

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

3Billion Joins Global iHope Program for Rare Disease Diagnosis: A Game-Changer for Patients in Asia

3Billion becomes the first Asian partner in the iHope program, enhancing rare disease diagnostics for underserved pediatric patients globally.

Discover the New Touch Prime Campaign for Ultherapy Prime™: Your Guide to Authentic Medical Aesthetics

Merz Aesthetics Korea launches Touch Prime campaign for Ultherapy Prime™, enhancing product authenticity verification via NFC technology.

GE Healthcare Partners with Daegu Miracle Women’s Hospital to Revolutionize Infertility Treatments in 2026

GE Healthcare Korea and Daegu Miracle Women's Hospital collaborate to enhance infertility treatment using advanced ultrasound technology.

HLB BioStep Signs Strategic MOU with CLIPS BnC… Toward Integrated Preclinical and Clinical Development

HLB BioStep and CLIPS BnC sign MOU to enhance collaboration between preclinical and clinical stages of drug development.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.